211 related articles for article (PubMed ID: 15685836)
1. Combined-modality therapy of rectal cancer with irinotecan-based regimens.
Minsky BD
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):49-55. PubMed ID: 15685836
[TBL] [Abstract][Full Text] [Related]
2. Combined-modality therapy for rectal cancer using irinotecan.
Minsky BD
Oncology (Williston Park); 2002 May; 16(5 Suppl 5):35-8. PubMed ID: 12109805
[TBL] [Abstract][Full Text] [Related]
3. Integration of novel agents into combined-modality treatment for rectal cancer patients.
Rödel C; Sauer R
Strahlenther Onkol; 2007 May; 183(5):227-35. PubMed ID: 17497093
[TBL] [Abstract][Full Text] [Related]
4. Combined-modality therapy of rectal cancer with oxaliplatin-based regimens.
Minsky BD
Clin Colorectal Cancer; 2004 Jun; 4 Suppl 1():S29-36. PubMed ID: 15212703
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].
Créhange G; Bosset JF; Maingon P
Cancer Radiother; 2011 Oct; 15(6-7):440-4. PubMed ID: 21802334
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan in preoperative combined-modality therapy for locally advanced rectal cancer.
Mitchell EP
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):56-9. PubMed ID: 11200151
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.
Mohiuddin M; Winter K; Mitchell E; Hanna N; Yuen A; Nichols C; Shane R; Hayostek C; Willett C;
J Clin Oncol; 2006 Feb; 24(4):650-5. PubMed ID: 16446336
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiation for rectal cancer: is more better?
Patel A; Puthillath A; Yang G; Fakih MG
Oncology (Williston Park); 2008 Jun; 22(7):814-26; discussion 826, 828-31, 836. PubMed ID: 18619122
[TBL] [Abstract][Full Text] [Related]
9. Current status of adjuvant therapy for colorectal cancer.
O'Connell MJ
Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy and rectal cancer].
Michel P; Di Fiore F
Cancer Radiother; 2011 Oct; 15(6-7):436-9. PubMed ID: 21885319
[TBL] [Abstract][Full Text] [Related]
11. Combined modality therapy of resectable rectal cancer: current approaches.
Minsky BD
Tech Coloproctol; 2004 Aug; 8(2):67-76. PubMed ID: 15309641
[TBL] [Abstract][Full Text] [Related]
12. Combined modality treatment for rectal cancer.
Zhu AX; Willett CG
Semin Oncol; 2005 Feb; 32(1):103-12. PubMed ID: 15726512
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer.
Hofheinz RD; Horisberger K; Woernle C; Wenz F; Kraus-Tiefenbacher U; Kähler G; Dinter D; Grobholz R; Heeger S; Post S; Hochhaus A; Willeke F
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1384-90. PubMed ID: 16979839
[TBL] [Abstract][Full Text] [Related]
14. [Principles of postoperative therapy in rectal carcinoma].
Folprecht G; Köhne CH
Chirurg; 2004 Jan; 75(1):32-7. PubMed ID: 14740125
[TBL] [Abstract][Full Text] [Related]
15. A Phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer.
Navarro M; Dotor E; Rivera F; Sánchez-Rovira P; Vega-Villegas ME; Cervantes A; García JL; Gallén M; Aranda E
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):201-5. PubMed ID: 16814947
[TBL] [Abstract][Full Text] [Related]
16. The use of capecitabine in the combined-modality therapy for rectal cancer.
Liauw SL; Minsky BD
Clin Colorectal Cancer; 2008 Mar; 7(2):99-104. PubMed ID: 18501068
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy of irinotecan, 5-fluorouracil and leucovorin in patients with advanced rectal cancer. Report of two cases.
Hasegawa H; Watanabe M; Baba H; Yoshinare K; Mukai M; Kubota T; Kitajima M
Hepatogastroenterology; 2002; 49(46):891-3. PubMed ID: 12143234
[TBL] [Abstract][Full Text] [Related]
18. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
[TBL] [Abstract][Full Text] [Related]
19. Medium-term results of neoadjuvant systemic chemotherapy using irinotecan, 5-fluorouracil, and leucovorin in patients with locally advanced rectal cancer.
Ishii Y; Hasegawa H; Endo T; Okabayashi K; Ochiai H; Moritani K; Watanabe M; Kitagawa Y
Eur J Surg Oncol; 2010 Nov; 36(11):1061-5. PubMed ID: 20538422
[TBL] [Abstract][Full Text] [Related]
20. Combined-modality therapy for rectal cancer: future prospects.
Czito BG; Willett CG; Bendell JC
Clin Colorectal Cancer; 2007 Sep; 6(9):625-33. PubMed ID: 17945034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]